Are you planning to launch a diagnostic alongside a targeted therapy in the next 18-24 months. This webinar highlights Diaceutics' recent PD-L1 lost therapy opportunity assessment, which demonstrated that every $1 spent on smart diagnostic efficiency returns between $20-$40 in additional therapy revenues otherwise lost. It also highlights how effective diagnostic planning can maximize your therapy revenue opportunity. Listen to this webinar to learn:
- that $1 spent on smart diagnostic efficiency returns between $20-$40 in additional therapy revenues otherwise lost; and
- why ineffective diagnostic launch planning can lead to lost therapy revenue and how, with the proper planning tools, the maximum therapy opportunity can be achieved.
